Intrexon Raises $100 M of Series E Funding
- ... What do you have to say? 0 Comments
Blacksburg, Virginia – Intrexon Corporation, a next generation biotechnology company announced that it has raised a huge Series E funding of $100 M from new venture capital firm Perella Weinberg Partners and backed up by existing investors. The new funding brings the company’s total capital funding to more than $259 million.
The latest funding will be utilized on Intrexon’s commercial divisions and the expansion of its UltraVector® platform.
UltraVector platform is the underlying architecture and construction methodology for the company’s complex transgenes, is the backbone of Intrexon’s activities in human health care, animal science, agricultural biotechnology and industrial products.
Funding Total: $100,000,000
|Round||Date||Amount||Pre Amount||Post Amount|
|Investors: Perella Weinberg Partners|